The Shriners Hospital for Children – Canada is the Canadian branch of the Shriners Hospitals for Children network. It is located in Notre-Dame-de-Grâce, Montreal, Quebec, at 1003 Decarie Boulevard.

There are 40 beds in Shriners Hospital for Children.

During the past decade, Shriners Hospital for Children conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 7 clinical trials were completed, i.e. on average, 63.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shriners Hospital for Children" #1 sponsor was "Baylor College of Medicine" with 3 trials, followed by "Shriners Hospitals for Children" with 3 trials sponsored, "Kyowa Hakko Kirin Pharma, Inc." with 2 trials sponsored, "Kyowa Kirin, Inc." with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shriners Hospital for Children" #1 collaborator was "Shriners Hospitals for Children" with 5 trials as a collaborator, "Kyowa Kirin Co., Ltd." with 4 trials as a collaborator, "University of Nebraska" with 3 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator and "Children's Mercy Hospital Kansas City" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Shriners Hospital for Children" are "Osteogenesis Imperfecta" (5 trials), "X-linked Hypophosphatemia" (3 trials), "Adolescent Idiopathic Scoliosis" (2 trials), "Cerebral Palsy" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Shriners Hospital for Children" in a lesser frequency.

Most popular intervention types in "Shriners Hospital for Children" are "Drug" (8 trials), "Other" (3 trials), "Biological" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "KRN23" (2 trials), "burosumab" (2 trials), "Alternative osteoporosis medications" (1 trials), "Botulinum toxin A injection" (1 trials) and "Brace" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shriners Hospital for Children" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Shriners Hospital for Children". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Shriners Hospital for Children, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Shriners Hospital for Children, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".